Tate & Lyle Keeps Full-Year Forecast on Sweetener Sales

Tate & Lyle Plc, the maker of low- calorie sweetener Splenda, said it’s “on track” to meet forecasts in the year ending March 31 as the company posted “solid” third-quarter sales amid rising corn prices.

The specialty food-ingredients division increased sales, fueled by “good” growth in corn-based sweeteners and starches, the London-based company said in a statement today. Sales increases of sucralose, sold under the Splenda brand, slowed in the quarter, it said. Bulk-ingredient sales expanded because of increased demand from the U.S. and Mexico.

Chief Executive Officer Javed Ahmed has sold Tate’s sugar interests to focus on more-profitable units, including specialty food ingredients. The company plans to restart sucralose production at a mothballed plant in Alabama later this year as demand increases for Splenda. The manufacturer reiterated it expects to “deliver a good performance for the full year.”

The quarter “continues to add to management’s credibility and track record of building a less volatile and more reliable business model,” Dirk Van Vlaanderen, an analyst at Jefferies International, said in a note to clients today.

The company widened its corn sugar profit margins even after paying higher prices for corn, Ahmed said in a conference call with analysts. Corn prices rose yesterday in Chicago following speculation that the U.S. Department of Agriculture may lower its estimate for global stockpiles.

Tate & Lyle fell 0.7 percent to 690 pence at 8:31 a.m. in London.

To contact the reporter on this story: Matthew Boyle in London at mboyle20@bloomberg.net

To contact the editor responsible for this story: Sara Marley at smarley1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.